54.800
+0,92%
2026-10-19
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -16.5% | +45.8% | 2 / 3 | +0.3% | -0.53 pp | -4.49 pp | +21.2% | 0.00 | 7.60 | 121 | +0,3% | 26,9 | −16,6% | 7.60 | 7.65 | −0,7% |
| Pts | 0 | 12 | 8 | 0 | 4 | 0 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 54.800 (close price on 2026-10-19)EPS (TTM): 7.215
Financial charts
1.Revenue & growth
VND bn121Q2/26
1.Revenue & growth
VND bn121Q2/26
2.Profit & growth
VND bn26,9Q2/26
3.Profit mix (Penman)
VND bn132Q2/26
4.Margins & cost structure
%37.1%Q2/26
5.Returns & cash cycle
% · days42.3%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn590Q2/26
8.Funding & debt health
VND bn · times590Q2/26
9.Revenue backlog
VND bn8,38Q2/26
10.Valuation
times · %7,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.781Q2/26
Adjusted EPS growth, latest quarter
-16.6%
Average adjusted EPS growth, 3 quarters
45.7%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26